Mylan CEO Heather Bresch listens to an aide during a hearing before lying to the House Oversight and Government Reform Committee on September 21, 2016 (Photo by Alex Wong/Getty Images) Mylan, the drug company that makes …
The Teva cash and stock proposal provides Mylan stockholders with a substantial premium and immediate cash value, as well as significant potential for future value creation through participation in a financially and commercially stronger …
PITTSBURGH, Pa. - The generic drugmaker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion. Mylan said Monday that the deal will diversify and expand its business …
(Kacik, 1/18) Modern Healthcare: Generic Drugmaker Stocks Dip Amid Reports Of Competition From Health Systems …
Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that …
Friday saw the return of volatility to the stock market, although major benchmarks recovered ... AMBA), Foundation Medicine (NASDAQ: FMI), and Mylan (NASDAQ: MYL) were among the best performers on the day. Below, we'll look …
Should I get rid of Mylan Labs, or hold on? A-You should love this stock. Hold and consider buying more shares of Mylan Laboratories Inc. (around $24 a share, New York Stock Exchange), because it is the class act in the generic drug …